What France Oxygène does

France Oxygène is a French home healthcare provider (Prestataire de Santé à Domicile, or PSAD) that has specialized in respiratory assistance since its founding in 1996 in Nord-Pas-de-Calais. The company delivers and maintains medical equipment for oxygen therapy, invasive and non-invasive ventilation, Continuous Positive Airway Pressure (CPAP/PPC) therapy, and aerosol therapy for patients at home, in hospitalization-at-home (HAD) settings, in nursing homes (EHPAD), and at vacation locations. Patients are predominantly individuals with chronic respiratory insufficiency — including COPD, sleep apnea, cystic fibrosis, severe asthma, emphysema, and facial vascular algias — referred by liberal physicians, hospital pulmonologists, and sleep laboratories. The company operates 12 regional agencies across Hauts-de-France, Grand-Est, Normandie, and Bourgogne-Franche-Comté, and is a wholly-owned subsidiary of SOL Group, the 3rd largest European gas provider, which it joined in 2000 to enable cross-border patient continuity.

The core technology stack is medical-device-centric rather than software-centric: France Oxygène deploys, maintains, and monitors respiratory equipment manufactured by Resmed, Philips Respironics, Lowenstein, GCE, Caire, Devilbiss, Breas, and Inogen. The company runs a prescriber portal (Espace Médecin / medecin.franceoxygene.fr) for healthcare-professional coordination, and in 2019 extended its platform with INFUSOL — a dedicated department for perfusion, nutrition, and insulinotherapy — and a VIVITRAVEL service that coordinates respiratory care across Europe through the SOL Group network. Cap'Air adapted physical-activity centers (Coudekerque-Branche and Lens) provide adjunct lifestyle programming for respiratory-insufficiency patients. France Oxygène and InfuSol obtained ISO 9001 certification in 2023.

The business model is a regulated, reimbursement-driven home healthcare service. As a licensed PSAD, France Oxygène is reimbursed by the French Assurance Maladie national health insurance system based on physician prescriptions, with supplementary insurers covering residual amounts; the company manages all administrative procedures on behalf of patients. Revenue is effectively recurring while a patient remains on therapy, with equipment installation, maintenance, consumables, therapeutic education, and 24/7 follow-up bundled into the per-patient tariff. The customer segments are individual chronic patients on the demand side and the national payer plus the prescriber channel on the supply side, creating a B2C/B2B2C GTM anchored on referral-driven acquisition and regulated reimbursement economics rather than direct-to-consumer marketing.

Name

France Oxygène

Legal name

FRANCE OXYGENE REGION NORD

Website

https://franceoxygene.fr

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

France Oxygène is a French home healthcare provider (PSAD), founded in 1996 and wholly-owned by SOL Group, delivering respiratory assistance — oxygen therapy, ventilation, CPAP, and aerosol therapy — to 75,000+ chronic patients across 12 agencies in Northern, Eastern, and Western France.

Ownership category

akta.pro rank

Product category

Home Healthcare / Respiratory Therapy Services

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

akta.pro secondary industries

Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Home Respiratory & Ventilator Care (Skilled) (HLADAFAI), Cardiac & Pulmonary Clinical Home Health (e.g., CHF/COPD) (HSABACAI)

Keywords

• Home respiratory assistance
• Oxygen therapy services
• Home healthcare provider
• Sleep apnea treatment
• Ventilation therapy

Headquarters

HQ city

Templemars

HQ country

France

HQ region

Europe

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Healthcare Reimbursement: As a French PSAD (Prestataire de Santé à Domicile), France Oxygène operates under the French national health insurance system. Services are reimbursed through the Assurance Maladie system based on prescriptions from physicians. The company manages all administrative procedures with health insurance funds and supplementary insurers.
2. Home Respiratory Assistance: Core revenue stream from providing oxygen therapy, ventilation (invasive and non-invasive), CPAP, and aerosol therapy to patients at home, in nursing homes, or during hospitalization at home.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

France Oxygène is a French home healthcare provider (Prestataire de Santé à Domicile, PSAD) that installs, maintains, and supports respiratory assistance equipment for patients at home. Its core services cover home oxygen therapy, invasive and non-invasive ventilation, Continuous Positive Airway Pressure (CPAP) for sleep apnea, and aerosol therapy, delivered 24/7 through 12 regional agencies across Northern, Eastern, and Western France under the French national health insurance reimbursement system.

Product overview

France Oxygène is a Prestataire de Santé à Domicile (PSAD) offering a comprehensive home healthcare platform centered on respiratory assistance. The core offering combines oxygen therapy, invasive and non-invasive ventilation, CPAP therapy, and aerosol therapy, supported by medical equipment provision from major manufacturers. The company has expanded through INFUSOL (perfusion/nutrition/insulinotherapy, 2019) and VIVITRAVEL (travel assistance), while Cap'Air centers provide adapted physical activity programs. The prescriber portal (Espace Médecin) enables healthcare professional coordination, all supported by 24/7 service and ISO 9001 certification.

Differentiator

Problem solved

Functional benefit

Brands

• Cap'Air: Club d'Activité Physique Adaptée pour Insuffisants Respiratoires - adapted physical activity centers for respiratory insufficiency patients, located in Coudekerque-Branche and Lens, Hauts-de-France.
• VIVITRAVEL

Products and services

• Oxygénothérapie à domicile (Home oxygen therapy) Home oxygen therapy service providing supplemental oxygen for patients with respiratory conditions such as COPD, emphysema, cystic fibrosis, and severe asthma who require oxygen support at home. The service includes equipment delivery, installation, and ongoing maintenance.
• Ventilation invasive et non invasive (Invasive and non-invasive ventilation) Respiratory ventilation services covering both invasive and non-invasive ventilation methods for patients requiring breathing assistance at home, including trachéotomie (tracheostomy) support.
• Pression Positive Continue (CPAP) therapy Continuous Positive Airway Pressure (CPAP) therapy for sleep apnea in adults, children, and central apnea cases, including device provision, installation, follow-up, and therapeutic education.
• Aérosolthérapie (Aerosol therapy) Aerosol therapy service providing nebulizer treatments for respiratory conditions such as severe asthma, cystic fibrosis, and other conditions requiring inhaled medication at home.
• INFUSOL (perfusion, nutrition, insulinothérapie) Dedicated home healthcare division created in 2019 to provide perfusion, nutrition, and insulinotherapy services, extending France Oxygène's home care coverage beyond respiratory assistance.
• VIVITRAVEL Travel solution program enabling respiratory assistance patients to travel or relocate freely across France and Europe while maintaining continuous respiratory therapy, coordinated via the SOL Group network.

Quantifiable outcome

• 75,000+ patients cared for at home, in HAD, in EHPAD, and at vacation locations

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core.

• SOL GroupcoreStrategic or Co-development Partner · 1 January 2000France Oxygène joined SOL Group, the 3rd largest European gas provider, in 2000. This integration facilitated patient care across France and Europe, enabling patients traveling or relocating to receive continued respiratory assistance through the group's network.
• Sleep Laboratories and HospitalscoreChannel Partner/ Reseller/ DistributorPartnerships with liberal prescribers, hospital physicians, and sleep laboratories who prescribe and refer patients requiring home respiratory assistance to France Oxygène.
• French National Health Insurance (Assurance Maladie)coreStrategic or Co-development PartnerCollaboration with the French national health insurance system for reimbursement of home healthcare services under regulated healthcare coverage.

Scale indicators4 records

Recent moves11 records

Expansion highlights4 records

Direct peers

• VitalAire (Air Liquide Healthcare): VitalAire is the home healthcare arm of Air Liquide, France's largest industrial gas group, and the leading national PSAD for home oxygen, ventilation, and CPAP — directly competing with France Oxygène across the same therapy categories and prescriber base.
• Orkyn' (Agir à Dom): Orkyn' (formerly Agir à Dom) is one of France's largest PSADs providing home respiratory assistance, perfusion, and nutrition services — a direct competitor with national coverage and a similarly diversified service portfolio.
• SOS Oxygène: SOS Oxygène is a French home respiratory assistance provider offering oxygen therapy, ventilation, and CPAP across multiple regions — directly comparable to France Oxygène in scope, services, and target patient population.
• ADEP Assistance: ADEP Assistance is a French home healthcare services provider focused on respiratory assistance, perfusion, and insulinotherapy — competing directly with France Oxygène's core and INFUSOL offerings.
• Bastide Le Confort Médical: Bastide Le Confort Médical is a French-listed provider of home medical equipment and respiratory services — a direct peer in oxygen therapy, ventilation, and CPAP provision with national distribution.
• LVL Médical: LVL Médical is a French PSAD specializing in home oxygen therapy and respiratory assistance — a direct regional and national competitor in the same prescription-driven service model.

Broad incumbents

• Air Liquide Healthcare: Air Liquide Healthcare is the global medical gas and home healthcare division of Air Liquide, operating VitalAire as its PSAD arm — a much larger incumbent competing with France Oxygène across home respiratory and broader home health services.
• Vivisol (SOL Group): Vivisol is SOL Group's home healthcare subsidiary operating across multiple European countries — a sister entity within the same parent group as France Oxygène, providing respiratory, sleep, and home infusion services.
• Linde Healthcare: Linde Healthcare (formerly Linde Gas Therapeutics) is the global medical gas and home respiratory arm of Linde Group — a broad incumbent offering comparable home oxygen and ventilation services across Europe.

Others

• Resmed: Resmed is a leading global manufacturer of CPAP, ventilation, and sleep apnea devices supplied to France Oxygène — an adjacent ecosystem participant and key equipment supplier rather than a direct service competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/france-oxygene-region-nord-sarl

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about France Oxygène